Transient myocardial ischemia in man, if sufficiently brief, is generally regarded as a reversible insult from which recovery is rapid and complete. Brief coronary artery occlusion in animal models, however, has shown that regional abnormalities of myocardial contraction can be prolonged, well beyond the period of ischemia. A preliminary investigation has demonstrated that repeated brief coronary occlusions can produce progressive and significant regional ventricular dysfunction without evidence of permanent cellular injury. Since recurrent brief episodes of ischemia are known to occur in man and may be frequent and without symptoms, it is important to define the consequences of these episodes on myocardial function. This proposal will examine abnormal mechanical function in a chronic dog model following repeated brief coronary occlusions. Regional function will be measured with implanted ultrasonic time transit gauges; myocardial blood flow will be quantitated from injections of radioactively labeled microspheres; and evidence of cellular damage will be determined from histochemical stains and histology. The degree and duration of mechanical impairment will be examined as a function of the number, frequency, and duration of ischemic episodes. An attempt will be made to determine the underlying pathophysiologic mechanism by quantitative measurements of adenine neucleotides, mitochondrial respiration, and sarcoplasmic reticulum calcium uptake. Finally, therapeutic strategies to reverse or prevent the mechanical dysfunction will be examined. These studies will define the functional significance of recurrent brief episodes of ischemia and may lead to new insight into the mechanism and therapy of ischemic cardiomyopathy.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08HL001170-03
Application #
3081701
Study Section
(SRC)
Project Start
1983-07-01
Project End
1988-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
3
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Greenhut, S E; Lee, J W; Monsur, J C et al. (1991) Computer analysis of physiologic signals in a cardiovascular research laboratory. Comput Biol Med 21:79-96
Nicklas, J M; McKenna, W J; Stewart, R A et al. (1991) Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy. Am Heart J 122:1016-21
Lincoff, A M; Popma, J J; Bates, E R et al. (1990) Successful coronary angioplasty in two patients with cardiogenic shock using the Nimbus Hemopump support device. Am Heart J 120:970-2
Greenhut, S E; Chadi, B H; Lee, J W et al. (1989) An algorithm for the quantification of ST-T segment variability. Comput Biomed Res 22:339-48
Nicklas, J M; Giacherio, D A; Moskowitz, D et al. (1989) Natriuresis associated with elevated plasma atrial natriuretic hormone during supraventricular tachycardia. Am Heart J 117:377-81
Nicklas, J M; Gips, S J (1989) Decreased coronary flow reserve after transient myocardial ischemia in dogs. J Am Coll Cardiol 13:195-9
Nicklas, J M; Topol, E J; Kander, N et al. (1989) Randomized, double-blind, placebo-controlled trial of tissue plasminogen activator in unstable angina. J Am Coll Cardiol 13:434-41
Nicklas, J M; Diltz, E A; O'Neill, W W et al. (1987) Quantitative measurement of coronary flow during medical revascularization (thrombolysis or angioplasty) in patients with acute infarction. J Am Coll Cardiol 10:284-9
Nicklas, J M; Greenhut, S E; Chadi, B H et al. (1987) Development of a template boundary algorithm to determine the ST-T threshold for silent ischemia. J Electrocardiol 20 Suppl:8-12
Nicklas, J M; DiCarlo, L A; Koller, P T et al. (1986) Plasma levels of immunoreactive atrial natriuretic factor increase during supraventricular tachycardia. Am Heart J 112:923-8